University Eye Clinic Dresden
Dresden, Saxony, 01307, Germany
NCT Number: NCT01741961
Long term results after Ahmed glaucoma valve implantation for uncontrolled glaucoma are retrospectively examined.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Dresden, Saxony, 01307, Germany
The development of intraocular pressure, visual acuity, number of glaucoma medication, number of complications and necessity of revision operations after Ahmed glaucoma valve implantation for uncontrolled glaucoma is examined yearly for a period of 4 years.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The flexible plate 7 (FP7) model (New World Medical) was implanted in patients with uncontrolled glaucoma.
Time frame: 4 years
The reduction of intraocular pressure after Ahmed glaucoma valve implantation is observed over a period of 4 years.
Time frame: 4 years
The development of visual acuity after Ahmed glaucoma valve implantation is being examined over a period of 4 years.
Time frame: 4 years
The number of glaucoma medication after Ahmed glaucoma valve implantation are being examined over a period of 4 years.
Time frame: 4 years
Possible postoperative complications after Ahmed glaucoma valve implantation are being examined over a period of 4 years.
Time frame: 4 years
The need for revision operations after Ahmed glaucoma valve implantation is being examined over a period of 4 years.
Technische Universität Dresden
Other
4-year Follow-up After Ahmed Glaucoma Valve Implantation for Lowering Intraocular Pressure in Different Types of Glaucoma
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06960629
Corneal Diseases, Corneal Edema
Zagreb, Croatia
View Trial DetailsNCT07730424
Eye Diseases, Glaucoma
Fitzroy, Victoria, Australia
View Trial DetailsNCT07168902
Eye Diseases, Glaucoma
Glendale, California, United States
View Trial DetailsNCT04132401
Age-Related Macular Degeneration, Cardiovascular Diseases
Manresa, Barcelona, Spain
View Trial Details